CRISPR Therapeutics AG (CRSP)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$35.61

Buy

$36.50

arrow-down$-0.52 (-1.44%)

CRISPR Therapeutics AG is a gene editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics.
Prices updated at 10 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up0%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$37.34 - $35.55
$67.88 - $30.04
-
3,076.27m
-
-
1,741,205
1.68
1,660,003.28
1.83
85.91m
CH0334081137
-4.49
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.